Cerebellar brain stimulation for SCA1 and SCA3 ataxia
Part of Brain & nervous system clinical trials.
This study tests a brain pacemaker (called deep brain stimulation) placed in the cerebellum to help improve balance and coordination in people with SCA1 or SCA3. It aims to see if this treatment can reduce ataxia symptoms and improve daily function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have a confirmed genetic diagnosis of SCA1 or SCA3 (with specific repeat sizes).
- You have moderate balance and coordination problems (measured by a standard scale).
- You have been on stable treatments for at least 3 months and still have ataxia symptoms.
- You are able to read at a 6th-grade level and speak English.
- You do not have severe memory loss, epilepsy, or major untreated psychiatric illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if deep brain stimulation (putting a device in the brain to send mild electrical pulses) can improve balance and movement in people with spinocerebellar ataxia type 6 (SCA6), a genetic condition that causes trouble walking and coordination.
This study tests a new kind of deep brain stimulation that adjusts automatically to improve balance and coordination in adults with SCA6, a genetic form of ataxia. It may help patients who can still walk but have moderate to severe symptoms.
This trial tests whether stimulating a part of the brain called the cerebellum with a device can help improve balance and coordination in people with primary ataxia (a movement disorder you were born with or inherited). It aims to see if this treatment is safe and effective over one year.
This trial tests a non-invasive brain stimulation method to see if it can improve movement and balance in people with spinocerebellar ataxia type 3. It aims to find the best settings for this treatment.
This study tests whether a non-invasive brain stimulation treatment (called cerebellar transcranial magnetic stimulation) can help improve balance and coordination in people with spinocerebellar ataxia. It may offer a new way to ease symptoms without surgery.
This trial tests an experimental stem cell treatment for people with SCA3, a genetic condition that affects balance and coordination. The goal is to see if the treatment can help improve or slow down these symptoms.
Hear when a new Spinocerebellar Ataxia Genotype Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.